Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: A prospective case-cohort study

The Lancet Respiratory Medicine

Volumn 1, Issue 9, 2013, Pages 685-694

  Morell, Ferran ^a,b   Villar, Ana ^a,b   Montero, María Ángeles ^a,c   Muñoz, Xavier ^a,b   Colby, Thomas V ^d   Pipvath, Sudhakar ^e   Cruz, María Jesús ^a,b   Raghu, Ganesh ^e  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN G;

ADULT; AGED; ALLERGIC PNEUMONITIS; ARTICLE; BRONCHIAL CHALLENGE TEST; CASE CONTROL STUDY; CHRONIC DISEASE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; EXPLANT; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOLOGY; LUNG BIOPSY; LUNG LAVAGE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROVOCATION TEST; PULMONOLOGIST; QUESTIONNAIRE; RADIOLOGIST; TISSUE CULTURE;

EID: 84887051071     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(13)70191-7     Document Type: Article

References (41)

1. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011, 183:788-824.
2. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006, 174:810-816.
3. Navaratnam V, Fleming KM, West J, et al. The rising incidence of idiopathic pulmonary fibrosis in the U.K. Thorax 2011, 66:462-467.
4. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000, 161:646-664. American Thoracic Society, American Thoracic Society (ATS)American Thoracic Society (ATS), the European Respiratory Society (ERS)the European Respiratory Society (ERS).
5. Ohtani Y, Saiki S, Kitaichi M, et al. Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax 2005, 60:665-671.
6. Trahan S, Hanak V, Ryu JH, Myers JL Role of surgical lung biopsy in separating chronic hypersensitivity pneumonia from usual interstitial pneumonia/idiopathic pulmonary fibrosis: analysis of 31 biopsies from 15 patients. Chest 2008, 134:126-132.
7. Corte TJ, Copley SJ, Desai SR, et al. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J 2012, 39:661-668.
8. Copley SJ, Wells AU, Sivakumaran P, et al. Asbestosis and idiopathic pulmonary fibrosis: comparison of thin-section CT features. Radiology 2003, 229:371-376.
9. Ohtani Y, Saiki S, Sumi Y, et al. Clinical features of recurrent and insidious chronic bird fancier's lung. Ann Allergy Asthma Immunol 2003, 90:604-610.
10. Curtis L, Lee BS, Cai D, et al. Pigeon allergens in indoor environments: a preliminary study. Allergy 2002, 57:627-631.
11. Morell F, Roger A, Reyes L, Cruz MJ, Murio C, Muñoz X Bird fancier's lung: a series of 86 patients. Medicine (Baltimore) 2008, 87:110-130.
12. Haitjema T, van Velzen-Blad H, van den Bosch JM Extrinsic allergic alveolitis caused by goose feathers in a duvet. Thorax 1992, 47:990-991.
13. Unoura K, Tomishima Y, Yasui M, et al. Chronic bird-related hypersensitivity pneumonitis presenting with exacerbation due to use of a feather duvet and improvement after antigen avoidance. Nihon Naika Gakkai Zasshi 2007, 96:344-346.
14. Koschel D, Wittstruck H, Renck T, Müller-Wening D, Höffken G Presenting features of feather duvet lung. Int Arch Allergy Immunol 2010, 152:264-270.
15. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002, 165:277-304. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias.
16. Ohshimo S, Bonella F, Cui A, et al. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009, 179:1043-1047.
17. Klech H, Pohl W Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group. Eur Respir J 1989, 2:561-585.
18. Chiba S, Okada S, Suzuki Y, et al. Cladosporium species-related hypersensitivity pneumonitis in household environments. Intern Med 2009, 48:363-367.
19. Othani Y, Ochi J, Mitaka K Chronic summer-type hypersensitivity pneumonitis initially misdiagnosed as idiopathic interstitial pneumonia. Intern Med 2008, 47:857-862.
20. Morell F Idiopathic pulmonary fibrosis: importance of accurate diagnosis and treatment. Arch Bronconeumol 2013, 49:319-320.
21. Gaxiola M, Buendía-Roldán I, Mejía M, et al. Morphologic diversity of pigeon breeder's disease: clinical features and survival. Respir Med 2011, 105:608-614.
22. Morell F, Roger A, Cruz MJ, Muñoz X, Rodrigo MJ Suberosis: clinical study and new etiologic agents in a series of eight patients. Chest 2003, 124:1145-1152.
23. Cruz MJ, Morell F, Roger A, Muñoz X, Rodrigo MJ Hypersensitivity pneumonitis in construction plasterers (espartosis): study of 20 patients. Med Clin (Barc) 2003, 120:578-583.
24. Morell F, Cruz MJ, Gómez FP, Rodríguez-Jerez F, Xaubet A, Muñoz X Chacinero's lung-hypersensitivity pneumonitis due to dry sausage dust. Scand J Work Environ Health 2011, 37:349-356.
25. Ramirez-Venegas A, Sansores RH, Perez-Padilla R, Carrillo G, Selman M Utility of a provocation test for diagnosis of chronic pigeon breeder's disease. Am J Respir Crit Care Med 1998, 158:862-869.
26. Munoz X, Morell F, Cruz MJ The use of specific inhalation challenge in hypersensitivity pneumonitis. Curr Opin Allergy Clin Immunol 2013, 13:151-158.
27. Sanchez M, Villar A, Cruz MJ, Morell F, Muñoz X. Diagnostic yield of specific inhalation challenge in patients with hypersensitivity pneumonitis. European Respiratory Society Congress; Vienna, Austria; Sept 1-5, 2012. Abstr P685.
28. Selman M, King TE, Pardo A Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2011, 134:136-151.
29. Metersky ML, Bean SB, Meyer JD, et al. Trombone player's lung: a probable new cause of hypersensitivity pneumonitis. Chest 2010, 138:754-756.
30. Metzger F, Haccuria A, Reboux G, Nolard N, Dalphin JC, De Vuyst P Hypersensitivity pneumonitis due to molds in a saxophone player. Chest 2010, 138:724-726.
31. Churg A, Sin DD, Everett D, Brown K, Cool C Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol 2009, 33:1765-1770.
32. Ryu YJ, Chung MP, Han J, et al. Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias. Respir Med 2007, 101:655-660.
33. Rosman MD, Kern JA, Elias JA, et al. Proliferative response of bronchoalveolar lymphocites to beryllium. A test for chronic beryllium disease. Ann Intern Med 1988, 108:687-693.
34. du Bois RM, Weycker D, Albera C, et al. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care 2011, 184:459-466.
35. Noble PW, Albera C, Bradford WZ, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 2011, 377:1760-1769. for the CAPACITY Study Group.
36. Raghu G, Brown KK, Bradford WZ, et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004, 350:125-133.
37. King TE, Brown KK, Raghu G, et al. BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011, 184:92-99.
38. Noth I, Anstrom KJ, Calvert SB, et al. A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2012, 186:88-95.
39. Raghu G, Anstrom KJ, King TE, Lasky JA, Martinez FJ Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012, 366:1968-1977. Idiopathic Pulmonary Fibrosis Clinical Research Network.
40. Richeldi L, Costabel U, Selman M, et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 2011, 365:1079-1087.
41. Raghu G, Behr J, Brown KK, et al. Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. Ann Intern Med 2013, 158:641-649.